a

Xtant Medical postpones Q3 2017 financial results release: 3 insights Featured

Written by  Mackenzie Garrity | Thursday, 09 November 2017 18:17
Social sharing

Xtant Medical postponed its Nov. 8, 2017, release of third quarter financial results.

Here are three insights:

 

1. Along with postponing the financial results, the medical device manufacture also rescheduled the following conference call, scheduled for Nov. 9.

 

2. Xtant plans to release its third quarter 2017 financial results by Nov. 20 in conjunction with the filing of its 10-Q.

 

3. Xtant develops, manufactures and markets regenerative medicine products, as well as orthopedic and neurological devices. Earlier this month, the company entered into a distribution agreement with Curasan, adding synthetic scaffolds to its biologics portfolio.

 

More articles on devices and implants:
Stryker, Smith & Nephew & more: 9 device company mergers, acquisitions and agreements
Global interventional spine devices market to expand at10.5% CAGR through 2021 — 4 notes
Mazor reports Q3 revenue at $17.2M, $3.7M net loss: 6 things to know

 

Last modified on Friday, 10 November 2017 21:01
© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months